NASDAQ:NBTX Nanobiotix (NBTX) Stock Forecast, Price & News $5.03 -0.21 (-4.01%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$5.00▼$5.1550-Day Range$1.98▼$6.6852-Week Range$1.75▼$7.76Volume18,095 shsAverage Volume2.20 million shsMarket Capitalization$175.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Nanobiotix (NASDAQ:NBTX) StockNanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.Read More Receive NBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. Email Address NBTX Stock News HeadlinesJune 1, 2023 | markets.businessinsider.comPre-market Movers: AGBA, QSG, AI, OKTA, AULT…May 18, 2023 | finanznachrichten.deNanobiotix S.A.: NANOBIOTIX Provides First Quarter 2023 Operational and Financial UpdateJune 4, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 17, 2023 | msn.comNanobiotix reports Q1 resultsMay 17, 2023 | finance.yahoo.comNANOBIOTIX Provides First Quarter 2023 Operational and Financial UpdateMay 5, 2023 | seekingalpha.comIBRX, TRUP and BAK among mid-day moversMay 5, 2023 | finance.yahoo.comNanobiotix Stock Triples In Trading Session: What's Going On With Stock On FridayMay 5, 2023 | markets.businessinsider.comNanobiotix Surges On Nearing A Contract Deal With A Major Pharma Co.June 4, 2023 | Vector Vest (Ad)Free Stock Analysis Report: Get Buy, Sell, or Hold RecommendationGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. May 5, 2023 | msn.comNanobiotix Soars on Potential Tie-Up with a Healthcare Major for Lead CandidateMay 5, 2023 | finance.yahoo.comNANOBIOTIX Entering Final Contract Negotiations Following Agreement to Non-Binding Term Sheet for Development and Commercialization of NBTXR3 With a Major Global Pharmaceutical CompanyApril 25, 2023 | msn.comWhy Are Nanobiotix Shares Plummeting Today?April 25, 2023 | benzinga.comNanobiotix shares are trading lower after the company reported full year 2022 financial results.April 24, 2023 | tmcnet.comNANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial ResultsApril 24, 2023 | msn.comEarnings Scheduled For April 24, 2023April 17, 2023 | finance.yahoo.comNANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023March 31, 2023 | uk.finance.yahoo.comNanobiotix S.A. (NANO.PA)March 30, 2023 | benzinga.comNanobiotix Stock (NASDAQ:NBTX), DividendsMarch 29, 2023 | seekingalpha.comNanobiotix postpones 2022 financial results releaseMarch 27, 2023 | finance.yahoo.comNanobiotix to Postpone Full Year 2022 Financial Results and Conference CallMarch 27, 2023 | americanbankingnews.comNanobiotix (NBTX) to Release Quarterly Earnings on TuesdayMarch 14, 2023 | finance.yahoo.comNanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023December 27, 2022 | msn.comNanobiotix randomizes 1st patient in US in phase 3 head/neck cancer trialDecember 27, 2022 | finance.yahoo.comNANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck CancerDecember 21, 2022 | finance.yahoo.comNANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract StatementDecember 8, 2022 | finance.yahoo.comVoting Rights and Shares Capital of the CompanyNovember 15, 2022 | finance.yahoo.comNANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx ConferenceSee More Headlines NBTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBTX Company Calendar Today6/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NBTX CUSIPN/A CIK1760854 Webwww.nanobiotix.com Phone33-1-40-26-04-70FaxN/AEmployees98Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.38 Quick Ratio1.38 Sales & Book Value Annual Sales$5.12 million Price / Sales34.27 Cash FlowN/A Price / Cash FlowN/A Book Value($0.82) per share Price / Book-6.13Miscellaneous Outstanding Shares34,880,000Free Float33,673,000Market Cap$175.45 million OptionableNot Optionable Beta0.08 Key ExecutivesMr. Laurent Levy Ph.D. (Age 49)Co-Founder, Pres of the Exec. Board & CEO Comp: $585.36kMr. Bart Van RhijnCFO & Member of Exec. BoardMs. Anne-Juliette Hermant M.A. (Age 48)Chief People Officer & Member of Exec. Board Comp: $304.33kProf. Para Prasad Ph.D. (Age 77)Co-Founder and Member of Scientific Board Mr. Earl J. Bergey Ph.d. (Age 67)Co-Founder Mr. Alain DostieChief Operating OfficerMs. Kathryn M. McNeil (Age 47)Sr. VP of Investor Relations Mr. Brandon OwensVP of Strategic Marketing & Corp. CommunicationMs. Elsa BorghiHead of Innovation & Drug DiscoveryMs. Sarah GaubertHead of Communication & Public Affairs DepartmentMore ExecutivesKey CompetitorsXBiotechNASDAQ:XBITOramed PharmaceuticalsNASDAQ:ORMPProPhase LabsNASDAQ:PRPHDURECTNASDAQ:DRRXLongboard PharmaceuticalsNASDAQ:LBPHView All Competitors NBTX Stock - Frequently Asked Questions How have NBTX shares performed in 2023? Nanobiotix's stock was trading at $3.67 at the beginning of the year. Since then, NBTX shares have increased by 37.1% and is now trading at $5.03. View the best growth stocks for 2023 here. Are investors shorting Nanobiotix? Nanobiotix saw a increase in short interest in May. As of May 15th, there was short interest totaling 73,200 shares, an increase of 850.6% from the April 30th total of 7,700 shares. Based on an average trading volume of 673,100 shares, the short-interest ratio is currently 0.1 days. Approximately 0.2% of the company's stock are short sold. View Nanobiotix's Short Interest. When did Nanobiotix IPO? (NBTX) raised $95 million in an IPO on Friday, December 11th 2020. The company issued 6,500,000 shares at $14.69 per share. Jefferies, Evercore ISI, UBS Investment Bank and Gilbert DuPont acted as the underwriters for the IPO. What is Nanobiotix's stock symbol? Nanobiotix trades on the NASDAQ under the ticker symbol "NBTX." How do I buy shares of Nanobiotix? Shares of NBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Nanobiotix's stock price today? One share of NBTX stock can currently be purchased for approximately $5.03. How much money does Nanobiotix make? Nanobiotix (NASDAQ:NBTX) has a market capitalization of $175.45 million and generates $5.12 million in revenue each year. How can I contact Nanobiotix? The official website for the company is www.nanobiotix.com. The company can be reached via phone at 33-1-40-26-04-70. This page (NASDAQ:NBTX) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.